- Report
- January 2024
- 120 Pages
Global
€4469EUR$4,995USD£3,929GBP
- Report
- October 2023
- 85 Pages
United States
From €4339EUR$4,850USD£3,815GBP
- Report
- July 2023
- 200 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- July 2023
- 218 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- January 2021
- 38 Pages
Global
€1179EUR$1,318USD£1,037GBP
- Report
- November 2022
- 79 Pages
Global
From €1789EUR$2,000USD£1,573GBP
- Report
- September 2024
- 89 Pages
Global
From €3500EUR$4,191USD£3,185GBP
- Report
- February 2024
- 96 Pages
Global
From €3500EUR$4,191USD£3,185GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$4,191USD£3,185GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$4,191USD£3,185GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$4,191USD£3,185GBP
- Report
- September 2022
- 86 Pages
Global
From €3500EUR$4,191USD£3,185GBP
- Report
- August 2024
- 93 Pages
Global
From €3500EUR$4,191USD£3,185GBP
- Report
- July 2024
- 103 Pages
Global
From €3500EUR$4,191USD£3,185GBP
- Book
- July 2018
- 257 Pages
- Report
- March 2025
- 78 Pages
China
From €1610EUR$1,800USD£1,416GBP
- Report
- August 2024
- 104 Pages
China
From €1610EUR$1,800USD£1,416GBP

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems.
Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea.
Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more